Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Increased PPARGC1α relates to hair thinning in common baldness.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Citrullus colocynthis fruit extract may effectively treat testosterone-related hair loss, similar to finasteride.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Androgens can help prevent memory problems caused by apoE4.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Excess maternal androgens can cause heart problems in offspring.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.